ViiV Wins Fast-Track Review At EMA For HIV Therapy

 
• By Neena Brizmohun

A number of new products have been submitted for review at the European Medicines Agency. While marketing authorization applications from ViiV Healthcare and BioMarin Pharmaceutical are being fast-tracked, a submission from Incyte is not.

Europe
New marketing applications for new drugs are under review in Europe • Source: Shutterstock

More from Europe

More from Geography